JAN 05, 2018 8:48 AM PST

New Scleroderma Treatment: Aggressive Stem Cell Transplant

WRITTEN BY: Kara Marker

A chronic autoimmune disease of the skin, called scleroderma, is not contagious or infectious and often not harmful. However, when this connective tissue disorder involves any internal organs, it can become dangerous. This is why scientists from Duke University developed a new, more aggressive way to treat scleroderma: a stem cell transplant procedure.

 Interstitial pulmonary fibrosis in Scleroderma. Credit: Yale Rosen

"In these severe cases, conventional drug therapies are not very effective long-term, so new approaches are a priority,” explained lead author Keith Sullivan, MD.

Scleroderma is normally characterized by varying levels of skin hardening, affecting around 300,000 Americans. Scientists know that it is caused by an overproduction of collagen, but not much else is known about how it develops. There is no known cure for scleroderma.

In the new Duke study, researchers tested the new stem cell therapy in a group of 36 scleroderma patients, who also received high-dose chemotherapy and whole-body radiation. The stem cell transplant therapy is designed to replace the patient’s defective immune system that is contributing to scleroderma with stem cells “treated to eliminate self-reacting lymphocytes.” Lymphocytes are cells of the immune system, and when they react with host cells, often called “self” cells, various autoimmune diseases can develop.

The outcomes of the patients receiving the transplant were compared to outcomes of 39 scleroderma patients who did not receive the experimental therapy but instead received a drug called cyclophosphamide, used to suppress the immune system as a treatment for scleroderma.

At the end of the study, which lasted for ten years, researchers found that transplant patients were less likely to continue using anti-scleroderma drugs (nine percent) than patients who did not receive stem cells (44 percent). Overall, survival also benefited the transplant patients most of all.

"Patients and their doctors should carefully weigh the pros and cons of intensive treatment with stem cell transplant, but this may hopefully set a new standard in this otherwise devastating autoimmune disease," Sullivan said. "These advances show the value of medical research and clinical trials in finding better therapies to advance health."

The present study was published in the New England Journal of Medicine.

Sources: Scleroderma Foundation, Duke University Medical Center

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 26, 2020
Immunology
Gearing up for Life: The First 7 Days of the Immune System
OCT 26, 2020
Gearing up for Life: The First 7 Days of the Immune System
The mother’s placenta serves as a shield for the developing fetus inside the womb, protecting it from the constant ...
OCT 29, 2020
Cell & Molecular Biology
How Does the Immune System Handle the Microbiome?
OCT 29, 2020
How Does the Immune System Handle the Microbiome?
The human body plays host to trillions of microbes, and many of them live in our gastrointestinal tract; these microorga ...
NOV 09, 2020
Microbiology
Fighting COVID-19 with Help From Llamas
NOV 09, 2020
Fighting COVID-19 with Help From Llamas
Camelids, which include llamas, alpacas and camels have immune systems that generate two kinds of antibodies when confro ...
FEB 10, 2021
Drug Discovery & Development
Black Men Respond Best to Immunotherapy for Prostate Cancer
FEB 10, 2021
Black Men Respond Best to Immunotherapy for Prostate Cancer
Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men f ...
FEB 23, 2021
Immunology
Immune Link Explains Why Personality Influences Mortality
FEB 23, 2021
Immune Link Explains Why Personality Influences Mortality
University of Limerick researchers have discovered direct links between the immune system, specific personality traits, ...
Loading Comments...